--- title: "Obsidian Therapeutics (OBX) news: merger" url: "https://aibio.space/companies/obsidian-therapeutics/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "OBX merger news: Galera and Obsidian Therapeutics merger moves forward with Gazelle Parent S-4. Obsidian Therapeutics, Inc. (NASDAQ: OBX), United States." --- OBX Obsidian Therapeutics, Inc. NASDAQ · United States # Obsidian Therapeutics (OBX) news OBX merger news Mergers · 2026-04-22 ## [Galera and Obsidian Therapeutics merger moves forward with Gazelle Parent S-4](https://aibio.space/news/galera-obsidian-therapeutics-merger-moves-forward-gazelle-parent-s-4/) Gazelle Parent, Inc. filed the registration statement on April 22, 2026. Galera has agreed to sell Series C preferred stock for about $350.0 million, less certain Obsidian financing proceeds, before the mergers close. ## Latest Obsidian Therapeutics news We have not published a story on Obsidian Therapeutics yet. When there is news, it will appear here. ## Obsidian Therapeutics at a glance - **Ticker**: OBX - **Listing**: NASDAQ - **Country**: United States ### Related companies - [BeyondSpring](https://aibio.space/companies/beyondspring/) NASDAQ: BYSI - [Lantern Pharma](https://aibio.space/companies/lantern-pharma/) NASDAQ: LTRN - [Atea Pharmaceuticals](https://aibio.space/companies/atea-pharmaceuticals/) NASDAQ: AVIR - [RISING BIOSCIENCES INC](https://aibio.space/companies/rising-biosciences/) OTC: RBII - [Windtree Therapeutics](https://aibio.space/companies/windtree-therapeutics/) OTC: WINT - [Lisata Therapeutics](https://aibio.space/companies/lisata-therapeutics/) NASDAQ: LSTA - [Eton Pharmaceuticals](https://aibio.space/companies/eton-pharmaceuticals/) NASDAQ: ETON - [Atara Biotherapeutics](https://aibio.space/companies/atara-biotherapeutics/) NASDAQ: ATRA ### Also on NASDAQ - [uniQure](https://aibio.space/companies/uniqure-n-v/) QURE - [Century Therapeutics](https://aibio.space/companies/century-therapeutics/) IPSC - [Spruce Biosciences](https://aibio.space/companies/spruce-biosciences/) SPRB - [MYRIAD GENETICS INC](https://aibio.space/companies/myriad-genetics/) MYGN - [Sagimet Biosciences](https://aibio.space/companies/sagimet-biosciences/) SGMT - [Advanced Biomed](https://aibio.space/companies/advanced-biomed/) ADVB ## Questions about Obsidian Therapeutics Is Obsidian Therapeutics involved in a merger or acquisition? Our latest story on this, dated Apr 22, 2026: "Galera and Obsidian Therapeutics merger moves forward with Gazelle Parent S-4". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/galera-obsidian-therapeutics-merger-moves-forward-gazelle-parent-s-4/). What is the ticker symbol of Obsidian Therapeutics? Obsidian Therapeutics, Inc. trades under the ticker OBX on NASDAQ. Where is Obsidian Therapeutics listed? Obsidian Therapeutics, Inc. is listed on NASDAQ. What is the SEC CIK of Obsidian Therapeutics? The SEC Central Index Key (CIK) for Obsidian Therapeutics, Inc. is 2130606. Its filings are on SEC EDGAR. How many shares does Obsidian Therapeutics have outstanding? 61,772,876 shares as of 2026-08-10, per the cover page of its 10-Q filed 2026-08-14. Which country or territory is Obsidian Therapeutics listed under? Our directory records Obsidian Therapeutics, Inc. under United States. What does Obsidian Therapeutics do? Our directory classifies Obsidian Therapeutics, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Obsidian Therapeutics? The ISIN recorded for Obsidian Therapeutics, Inc. is US67448A1060. Does aibio.space cover Obsidian Therapeutics? aibio.space lists Obsidian Therapeutics, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What is the latest Obsidian Therapeutics (OBX) stock news? Our latest story on Obsidian Therapeutics, dated Apr 22, 2026: "Galera and Obsidian Therapeutics merger moves forward with Gazelle Parent S-4". Gazelle Parent, Inc. filed the registration statement on April 22, 2026. Galera has agreed to sell Series C preferred stock for about $350.0 million, less certain Obsidian financing proceeds, before the mergers close. [Source](https://aibio.space/news/galera-obsidian-therapeutics-merger-moves-forward-gazelle-parent-s-4/). How long will Obsidian Therapeutics's cash last? From our story of Apr 22, 2026: It says existing cash plus net proceeds of the mergers and concurrent financing will fund operations into the third quarter of 2026. [Source](https://aibio.space/news/galera-obsidian-therapeutics-merger-moves-forward-gazelle-parent-s-4/). How much cash does Obsidian Therapeutics have? From our story of Apr 22, 2026: One risk factor reports $80.5 million of cash, cash equivalents and marketable securities as of December 31, 2025. [Source](https://aibio.space/news/galera-obsidian-therapeutics-merger-moves-forward-gazelle-parent-s-4/). Is Obsidian Therapeutics a smaller reporting company? SEC records list Obsidian Therapeutics, Inc.'s filer category as: Non-accelerated filer
Emerging growth company. Where is Obsidian Therapeutics headquartered? SEC records list its business address as 1030 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138. When does Obsidian Therapeutics's fiscal year end? Obsidian Therapeutics, Inc.'s fiscal year ends on December 31, per SEC records. ## Investor discussion: Obsidian Therapeutics Members talk about Obsidian Therapeutics (OBX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Obsidian Therapeutics, newest first. Each line links the filing it comes from. 1. 2026-08-28 Financings Filed a registration statement for a share offering. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/2130606/000119312526374729/d127696ds1.htm) 2. 2026-08-03 Legal Reported a change of independent auditor. SEC Form 8-K (Items 1.01,2.01,2.02,3.02,3.03,4.01,5.01,5.02,5.03,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/d309963dex991.htm) 3. 2026-04-22 Mergers Filed documents for a merger or acquisition. SEC Form S-4. [Source](https://www.sec.gov/Archives/edgar/data/2130606/000119312526170834/d117787ds4.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:OBX on TradingView](https://www.tradingview.com/symbols/NASDAQ-OBX/). ## SEC filings and registration - **SEC name**: Obsidian Therapeutics, Inc. - **CIK**: 2130606 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: OBX (Nasdaq) - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Emerging growth company - **Business address**: 1030 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138 - **Phone**: (781) 806-6245 - **Shares outstanding**: 61,772,876 as of 2026-08-10 (10-Q filed 2026-08-14) - **Former names**: Gazelle Parent, Inc. ### Recent filings (8-K and 6-K are the company's own announcements) - [S-1](https://www.sec.gov/Archives/edgar/data/2130606/000119312526374729/d127696ds1.htm) filed 2026-08-28 - [10-Q](https://www.sec.gov/Archives/edgar/data/2130606/000119312526352381/obx-20260630.htm) filed 2026-08-14 - [8-K](https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/d309963d8k.htm) filed 2026-08-03 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002130606), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Obsidian Therapeutics, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker OBX, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Obsidian Therapeutics, Inc. - **Ticker**: OBX - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US67448A1060 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-OBX/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/obsidian-therapeutics/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Obsidian Therapeutics (OBX) news: merger", 2026-10-31, https://aibio.space/companies/obsidian-therapeutics/